Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Efficacy of a Selective Binder of αVβ3 Integrin Linked to the Tyrosine Kinase Inhibitor Sunitinib in Ovarian Carcinoma Preclinical Models.

Sartori A, Corno C, De Cesare M, Scanziani E, Minoli L, Battistini L, Zanardi F, Perego P.

Cancers (Basel). 2019 Apr 13;11(4). pii: E531. doi: 10.3390/cancers11040531.

2.

KiSS1 in regulation of metastasis and response to antitumor drugs.

Corno C, Perego P.

Drug Resist Updat. 2019 Jan;42:12-21. doi: 10.1016/j.drup.2019.02.001. Epub 2019 Feb 11. Review.

PMID:
30776659
3.

Alterations of RNA Metabolism by Proteomic Analysis of Breast Cancer Cells Exposed to Marycin: A New Optically Active Porphyrin.

Taverna E, De Bortoli M, Maffioli E, Corno C, Ciusani E, Trivulzio S, Pinelli A, Tedeschi G, Perego P, Bongarzone I.

Curr Mol Pharmacol. 2019;12(2):147-159. doi: 10.2174/1874467212666190204102112.

PMID:
30714537
4.

Role of FoxO Proteins in Cellular Response to Antitumor Agents.

Beretta GL, Corno C, Zaffaroni N, Perego P.

Cancers (Basel). 2019 Jan 14;11(1). pii: E90. doi: 10.3390/cancers11010090. Review.

5.

FoxO-1 contributes to the efficacy of the combination of the XPO1 inhibitor selinexor and cisplatin in ovarian carcinoma preclinical models.

Corno C, Stucchi S, De Cesare M, Carenini N, Stamatakos S, Ciusani E, Minoli L, Scanziani E, Argueta C, Landesman Y, Zaffaroni N, Gatti L, Perego P.

Biochem Pharmacol. 2018 Jan;147:93-103. doi: 10.1016/j.bcp.2017.11.009. Epub 2017 Nov 16.

PMID:
29155058
6.

Axl molecular targeting counteracts aggressiveness but not platinum-resistance of ovarian carcinoma cells.

Corno C, Gatti L, Arrighetti N, Carenini N, Zaffaroni N, Lanzi C, Perego P.

Biochem Pharmacol. 2017 Jul 15;136:40-50. doi: 10.1016/j.bcp.2017.04.002. Epub 2017 Apr 9.

PMID:
28404378
7.

Role of the Receptor Tyrosine Kinase Axl and its Targeting in Cancer Cells.

Corno C, Gatti L, Lanzi C, Zaffaroni N, Colombo D, Perego P.

Curr Med Chem. 2016;23(15):1496-512. Review.

PMID:
27048336
8.

Drug Combinations with HDAC Inhibitors in Antitumor Therapy.

Arrighetti N, Corno C, Gatti L.

Crit Rev Oncog. 2015;20(1-2):83-117. Review.

PMID:
25746106
9.

[Prevalence and significance of type-2 diabetes mellitus in chronic liver disease, correlated with hepatitis C virus].

Brischetto R, Corno C, Amore MG, Leotta S, Pavone S, Bonsignore L, Calcagno MP, Calcara G.

Ann Ital Med Int. 2003 Jan-Mar;18(1):31-6. Italian.

PMID:
12739426

Supplemental Content

Loading ...
Support Center